Dalus, Nurmalyn .

HRN: 25-74-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2024
CEFUROXIME 1.5GM (VIAL)
08/27/2024
08/28/2024
IV
1.6gm 2 Doses
Q8
Post Cs
Waiting Final Action 
08/27/2024
CEFUROXIME 500MG (TAB)
08/27/2024
09/02/2024
PO
500mg
BID
Post Cs
Waiting Final Action 
08/28/2024
CEFUROXIME 500MG (TAB)
08/28/2024
09/03/2024
PO
500 Mg
BID
Sp 1 LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: